Krystal Biotech, Inc. KRYS Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s operating cash flow?
- Krystal Biotech, Inc. (KRYS) reported operating cash flow of $80.38M in Q1 2026.
- How has Krystal Biotech, Inc.'s operating cash flow changed year-over-year?
- Krystal Biotech, Inc.'s operating cash flow increased by 159.6% year-over-year, from $30.97M to $80.38M.
- What is the long-term trend for Krystal Biotech, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s operating cash flow has grown at a 43.1% compound annual growth rate (CAGR), from -$47.94M to $200.87M.
- What does operating cash flow mean?
- The net cash flow resulting from the company's primary business activities.
- How do you interpret operating cash flow?
- Higher values indicate strong operational health and the ability to self-fund, while negative values may signal a need for external capital.
- How does operating cash flow compare across companies?
- The most fundamental metric for comparing operational performance across all public companies.